86 related articles for article (PubMed ID: 20562095)
1. A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.
Eefting D; Seghers L; Grimbergen JM; de Vries MR; de Boer HC; Lardenoye JW; Jukema JW; van Bockel JH; Quax PH
Cardiovasc Res; 2010 Nov; 88(2):367-75. PubMed ID: 20562095
[TBL] [Abstract][Full Text] [Related]
2. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
[TBL] [Abstract][Full Text] [Related]
3. In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.
Lamfers ML; Lardenoye JH; de Vries MR; Aalders MC; Engelse MA; Grimbergen JM; van Hinsbergh VW; Quax PH
Gene Ther; 2001 Apr; 8(7):534-41. PubMed ID: 11319620
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice.
Karper JC; de Vries MR; van den Brand BT; Hoefer IE; Fischer JW; Jukema JW; Niessen HW; Quax PH
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1033-40. PubMed ID: 21330606
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral gene transfer of a u-PA receptor-binding plasmin inhibitor and green fluorescent protein: inhibition of migration and visualization of expression.
Lamfers ML; Wijnberg MJ; Grimbergen JM; Huisman LG; Aalders MC; Cohen FN; Verheijen JH; van Hinsbergh VW; Quax PH
Thromb Haemost; 2000 Sep; 84(3):460-7. PubMed ID: 11019972
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.
Quax PH; Lamfers ML; Lardenoye JH; Grimbergen JM; de Vries MR; Slomp J; de Ruiter MC; Kockx MM; Verheijen JH; van Hinsbergh VW
Circulation; 2001 Jan; 103(4):562-9. PubMed ID: 11157723
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
[TBL] [Abstract][Full Text] [Related]
9. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
12. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
Schepers A; Eefting D; Bonta PI; Grimbergen JM; de Vries MR; van Weel V; de Vries CJ; Egashira K; van Bockel JH; Quax PH
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2063-9. PubMed ID: 16825596
[TBL] [Abstract][Full Text] [Related]
13. Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice.
Feng Y; Gordts SC; Chen F; Hu Y; Van Craeyveld E; Jacobs F; Carlier V; Feng Y; Zhang Z; Xu Q; Ni Y; De Geest B
Atherosclerosis; 2011 Feb; 214(2):271-8. PubMed ID: 20943224
[TBL] [Abstract][Full Text] [Related]
14. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
15. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
16. Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in vivo.
Okada SS; Golden MA; Raghunath PN; Tomaszewski JE; David ML; Kuo A; Kariko K; Barnathan ES
Thromb Haemost; 1998 Jul; 80(1):140-7. PubMed ID: 9684800
[TBL] [Abstract][Full Text] [Related]
17. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.
van der Laan WH; Pap T; Ronday HK; Grimbergen JM; Huisman LG; TeKoppele JM; Breedveld FC; Gay RE; Gay S; Huizinga TW; Verheijen JH; Quax PH
Arthritis Rheum; 2000 Aug; 43(8):1710-8. PubMed ID: 10943860
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins.
George SJ; Baker AH; Angelini GD; Newby AC
Gene Ther; 1998 Nov; 5(11):1552-60. PubMed ID: 9930309
[TBL] [Abstract][Full Text] [Related]
19. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
20. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
